Table 3: Incidence of ≥ Grade 3 adverse event in sunitinib-treated patients classified by age.

Contents Variable P value
Age < 75 years (n = 38) Age ≥ 75 years (n = 9)
+ - + -
≥ Grade 3 in all Adverse Events 30 (79) 8 (21) 9 (100) 0 (0) 0.1308
≥ Grade 3 in symptoms 9 (24) 29 (76) 5 (56) 4 (44) 0.0601
≥ Grade 3 in Abnormal laboratory data 25 (66) 13 (34) 5 (56) 4 (44) 0.5656